CMPS Stock Price
COMPASS Pathways plc
CMPS stock price is $11.27 (+1.17% on the day), giving COMPASS Pathways plc a market cap of $1.56B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
CMPS Stock Overview
- Price
- $11.27
- Previous close
- $11.14
- Open
- $11.09
- Market cap
- $1.56B
- P/E ratio
- -10.1
- 52-week range
- $4.88 - $15.87
- 1-year price target
- $23.21
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Exchange
- NGS
- MarketXLS Rank
- 31
About COMPASS Pathways plc
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CMPS | $11.27 | +1.2% | 2.53M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |